{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:05:21Z","timestamp":1773101121414,"version":"3.50.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Process PR2-0101-00054.01.00\/15"],"award-info":[{"award-number":["Process PR2-0101-00054.01.00\/15"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Process PR2-0101-00054.01.00\/15"],"award-info":[{"award-number":["Process PR2-0101-00054.01.00\/15"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Process PR2-0101-00054.01.00\/15"],"award-info":[{"award-number":["Process PR2-0101-00054.01.00\/15"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Process PR2-0101-00054.01.00\/15"],"award-info":[{"award-number":["Process PR2-0101-00054.01.00\/15"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Process PR2-0101-00054.01.00\/15"],"award-info":[{"award-number":["Process PR2-0101-00054.01.00\/15"]}],"id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Process PR2-0101-00054.01.00\/15"],"award-info":[{"award-number":["Process PR2-0101-00054.01.00\/15"]}],"id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Process PR2-0101-00054.01.00\/15"],"award-info":[{"award-number":["Process PR2-0101-00054.01.00\/15"]}],"id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["Process PR2-0101-00054.01.00\/15"],"award-info":[{"award-number":["Process PR2-0101-00054.01.00\/15"]}],"id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00210-025-04216-6","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:13:59Z","timestamp":1745997239000},"page":"14515-14535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analgesic and neuroprotective effect of a lipid transfer protein isolated from Morinda citrifolia L. (noni) seeds on oxaliplatin-induced peripheral sensory neuropathy in mice"],"prefix":"10.1007","volume":"398","author":[{"given":"Francisco Rafael Alves Santana","family":"Ces\u00e1rio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas Costa","family":"de Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamaria Falc\u00e3o","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Bernardo Souza","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Rocha","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Santos","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula Negreiros Nunes","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nylane Maria Nunes","family":"de Alencar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herm\u00f3genes David","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Lima","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"4216_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/advs.202101717","volume":"8","author":"A Aierken","year":"2021","unstructured":"Aierken A, Xie YK, Dong W et al (2021) Rational design of a modality-specific inhibitor of TRPM8 channel against oxaliplatin-induced cold allodynia. Adv Sci 8:1\u201311. https:\/\/doi.org\/10.1002\/advs.202101717","journal-title":"Adv Sci"},{"key":"4216_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3747\/co.v18i1.708","volume":"18","author":"T Alcindor","year":"2011","unstructured":"Alcindor T, Beauger N (2011) Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol 18:18\u201325. https:\/\/doi.org\/10.3747\/co.v18i1.708","journal-title":"Curr Oncol"},{"key":"4216_CR3","first-page":"331","volume":"36","author":"LM Alejandro","year":"2013","unstructured":"Alejandro LM, Behrendt CE, Chen K et al (2013) Predicting acute and persistent neuropathy associated with oxaliplatin. Am J Clin Oncol Cancer Clin Trials. 36:331\u2013337","journal-title":"Am J Clin Oncol Cancer Clin Trials."},{"key":"4216_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/01480545.2017.1384835","volume":"41","author":"MAY Alqudah","year":"2018","unstructured":"Alqudah MAY, Al-Ashwal FY, Alzoubi KH et al (2018) Vitamin E protects human lymphocytes from genotoxicity induced by oxaliplatin. Drug Chem Toxicol 41:281\u2013286. https:\/\/doi.org\/10.1080\/01480545.2017.1384835","journal-title":"Drug Chem Toxicol"},{"key":"4216_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1744-8069-6-82","volume":"6","author":"U Anand","year":"2010","unstructured":"Anand U, Otto WR, Anand P (2010) Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons. Mol Pain 6:82. https:\/\/doi.org\/10.1186\/1744-8069-6-82","journal-title":"Mol Pain"},{"key":"4216_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/toxics3020187","volume":"3","author":"AA Argyriou","year":"2015","unstructured":"Argyriou AA (2015) Updates on oxaliplatin-induced peripheral neurotoxicity (OXAIPN). Toxics 3:187\u2013197. https:\/\/doi.org\/10.3390\/toxics3020187","journal-title":"Toxics"},{"key":"4216_CR7","doi-asserted-by":"publisher","unstructured":"Azevedo MI, Pereira AF, Nogueira RB et al (2013) The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Mol Pain 9. https:\/\/doi.org\/10.1186\/1744-8069-9-53","DOI":"10.1186\/1744-8069-9-53"},{"key":"4216_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/PTR.2863","volume":"24","author":"S Basar","year":"2010","unstructured":"Basar S, Uhlenhut K, H\u00f6gger P et al (2010) Analgesic and antiinflammatory activity of Morinda citrifolia L. (Noni) fruit. Phytother Res 24:38\u201342. https:\/\/doi.org\/10.1002\/PTR.2863","journal-title":"Phytother Res"},{"key":"4216_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/ABIO.1976.9999","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1006\/ABIO.1976.9999","journal-title":"Anal Biochem"},{"key":"4216_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"4216_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/J.PAIN.2010.05.005","volume":"150","author":"JM Br\u00e1z","year":"2010","unstructured":"Br\u00e1z JM, Basbaum AI (2010) Differential ATF3 expression in dorsal root ganglion neurons reveals the profile of primary afferents engaged by diverse noxious chemical stimuli. Pain 150:290\u2013301. https:\/\/doi.org\/10.1016\/J.PAIN.2010.05.005","journal-title":"Pain"},{"key":"4216_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0006-8993(92)90941-2","volume":"580","author":"E Bullitt","year":"1992","unstructured":"Bullitt E, Lee CL, Light AR, Willcockson H (1992) The effect of stimulus duration on noxious-stimulus induced c-fos expression in the rodent spinal cord. Brain Res 580:172\u2013179. https:\/\/doi.org\/10.1016\/0006-8993(92)90941-2","journal-title":"Brain Res"},{"key":"4216_CR13","doi-asserted-by":"publisher","first-page":"113141","DOI":"10.1016\/j.expneurol.2019.113141","volume":"325","author":"A Calls","year":"2020","unstructured":"Calls A, Carozzi V, Navarro X et al (2020) Pathogenesis of platinum-induced peripheral neurotoxicity: insights from preclinical studies. Exp Neurol 325:113141","journal-title":"Exp Neurol"},{"key":"4216_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijbiomac.2016.01.029","volume":"86","author":"DCO Campos","year":"2016","unstructured":"Campos DCO, Costa AS, Lima ADR et al (2016) First isolation and antinociceptive activity of a lipid transfer protein from noni (Morinda citrifolia) seeds. Int J Biol Macromol 86:71\u201379. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.01.029","journal-title":"Int J Biol Macromol"},{"key":"4216_CR15","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.ijbiomac.2017.05.148","volume":"103","author":"DCO Campos","year":"2017","unstructured":"Campos DCO, Costa AS, Luz PB et al (2017) Morinda citrifolia lipid transfer protein 1 exhibits anti-inflammatory activity by modulation of pro- and anti-inflammatory cytokines. Int J Biol Macromol 103:1121\u20131129. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.05.148","journal-title":"Int J Biol Macromol"},{"key":"4216_CR16","doi-asserted-by":"publisher","unstructured":"Caspani O, Zurborg S, Labuz D, Heppenstall PA (2009) The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One 4. https:\/\/doi.org\/10.1371\/journal.pone.0007383","DOI":"10.1371\/journal.pone.0007383"},{"key":"4216_CR17","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/cancers12061370","volume":"12","author":"G Cavaletti","year":"2020","unstructured":"Cavaletti G, Marmiroli P (2020) Management of oxaliplatin-induced peripheral sensory neuropathy. Cancers (Basel) 12:1370","journal-title":"Cancers (Basel)"},{"key":"4216_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuro.2020.06.005","volume":"80","author":"H Celik","year":"2020","unstructured":"Celik H, Kucukler S, Ozdemir S et al (2020) Lycopene protects against central and peripheral neuropathy by inhibiting oxaliplatin-induced ATF-6 pathway, apoptosis, inflammation and oxidative stress in brains and sciatic tissues of rats. Neurotoxicology 80:29\u201340. https:\/\/doi.org\/10.1016\/j.neuro.2020.06.005","journal-title":"Neurotoxicology"},{"key":"4216_CR19","doi-asserted-by":"publisher","unstructured":"Chanthira Kumar H, Lim XY, Mohkiar FH et al (2022) Efficacy and safety of Morinda citrifolia L. (Noni) as a potential anticancer agent. Integr Cancer Ther 21. https:\/\/doi.org\/10.1177\/15347354221132848","DOI":"10.1177\/15347354221132848"},{"key":"4216_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrclinonc.2015.129","volume":"12","author":"C Cremolini","year":"2015","unstructured":"Cremolini C, Schirripa M, Antoniotti C et al (2015) First-line chemotherapy for mCRC-a review and evidence-based algorithm. Nat Rev Clin Oncol 12:607\u2013619","journal-title":"Nat Rev Clin Oncol"},{"key":"4216_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1590\/S0100-879X2004000300018","volume":"37","author":"TM Cunha","year":"2004","unstructured":"Cunha TM, Verri WA Jr, Vivancos GG et al (2004) An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37:401\u2013407. https:\/\/doi.org\/10.1590\/S0100-879X2004000300018","journal-title":"Braz J Med Biol Res"},{"key":"4216_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/emmm.201100134","volume":"3","author":"J Descoeur","year":"2011","unstructured":"Descoeur J, Pereira V, Pizzoccaro A et al (2011) Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med 3:266\u2013278. https:\/\/doi.org\/10.1002\/emmm.201100134","journal-title":"EMBO Mol Med"},{"key":"4216_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpain.2011.11.009","volume":"13","author":"L Di Cesare Mannelli","year":"2012","unstructured":"Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C (2012) Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J Pain 13:276\u2013284. https:\/\/doi.org\/10.1016\/j.jpain.2011.11.009","journal-title":"J Pain"},{"key":"4216_CR24","doi-asserted-by":"publisher","first-page":"e0128080","DOI":"10.1371\/journal.pone.0128080","volume":"10","author":"L Di Cesare Mannelli","year":"2015","unstructured":"Di Cesare Mannelli L, Pacini A, Corti F et al (2015) Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity. PLoS ONE 10:e0128080. https:\/\/doi.org\/10.1371\/journal.pone.0128080","journal-title":"PLoS ONE"},{"key":"4216_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","volume":"77","author":"S Dilruba","year":"2016","unstructured":"Dilruba S, Kalayda GV (2016) Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol 77:1103\u20131124","journal-title":"Cancer Chemother Pharmacol"},{"key":"4216_CR26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00210-022-02267-7","volume":"395","author":"LD do Carmo","year":"2022","unstructured":"do Carmo LD, de F\u00e1tima Pinheiro Rangel G, Rabelo LMA et al (2022) Therapeutic effects of a lipid transfer protein isolated from Morinda citrifolia L. (noni) seeds on irinotecan-induced intestinal mucositis in mice. Naunyn Schmiedebergs Arch Pharmacol 395:1097\u20131107. https:\/\/doi.org\/10.1007\/s00210-022-02267-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4216_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0076-6879(90)86135-I","volume":"186","author":"HH Draper","year":"1990","unstructured":"Draper HH, Hadley M (1990) [43] Malondialdehyde determination as index of lipid Peroxidation. Methods Enzymol 186:421\u2013431. https:\/\/doi.org\/10.1016\/0076-6879(90)86135-I","journal-title":"Methods Enzymol"},{"key":"4216_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/bja\/aex229","volume":"119","author":"SJL Flatters","year":"2017","unstructured":"Flatters SJL, Dougherty PM, Colvin LA (2017) Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. Br J Anaesth 119:737\u2013749. https:\/\/doi.org\/10.1093\/bja\/aex229","journal-title":"Br J Anaesth"},{"key":"4216_CR29","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/PTR.1307","volume":"17","author":"E Furusawa","year":"2003","unstructured":"Furusawa E, Hirazumi A, Story S, Jensen J (2003) Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascites tumour in mice. Phytother Res 17:1158\u20131164. https:\/\/doi.org\/10.1002\/PTR.1307","journal-title":"Phytother Res"},{"key":"4216_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2009.04.029","volume":"458","author":"P Gauchan","year":"2009","unstructured":"Gauchan P, Andoh T, Kato A, Kuraishi Y (2009) Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice. Neurosci Lett 458:93\u201395. https:\/\/doi.org\/10.1016\/j.neulet.2009.04.029","journal-title":"Neurosci Lett"},{"key":"4216_CR31","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1111\/BPH.16429","volume":"181","author":"MS Gold","year":"2024","unstructured":"Gold MS, Pineda-Farias JB, Close D et al (2024) Subcutaneous administration of a novel TRPM8 antagonist reverses cold hypersensitivity while attenuating the drop in core body temperature. Br J Pharmacol 181:3527\u20133543. https:\/\/doi.org\/10.1111\/BPH.16429","journal-title":"Br J Pharmacol"},{"key":"4216_CR32","doi-asserted-by":"publisher","unstructured":"Gondinho P de AR, de Barros Silva PG, Lisboa MRP et al (2020) FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study. Int J Clin Oncol 1\u20139. https:\/\/doi.org\/10.1007\/s10147-020-01757-z","DOI":"10.1007\/s10147-020-01757-z"},{"issue":"4 Suppl 15","key":"4216_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0093-7754(03)00399-3","volume":"30","author":"A Grothey","year":"2003","unstructured":"Grothey A (2003) Oxaliplatin-safety profile: neurotoxicity. Semin Oncol 30(4 Suppl 15):5\u201313. https:\/\/doi.org\/10.1016\/s0093-7754(03)00399-3","journal-title":"Semin Oncol"},{"key":"4216_CR34","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.neuroscience.2009.10.064","volume":"165","author":"MV Hamity","year":"2010","unstructured":"Hamity MV, White SR, Hammond DL (2010) Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception. Neuroscience 165:902\u2013913. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.10.064","journal-title":"Neuroscience"},{"key":"4216_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0361-9230(97)00277-3","volume":"45","author":"JA Harris","year":"1998","unstructured":"Harris JA (1998) Using c-fos as a neural marker of pain. Brain Res Bull 45:1\u20138. https:\/\/doi.org\/10.1016\/S0361-9230(97)00277-3","journal-title":"Brain Res Bull"},{"key":"4216_CR36","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1158\/1078-0432.CCR-13-3141","volume":"20","author":"SV Hato","year":"2014","unstructured":"Hato SV, Khong A, De Vries IJM, Lesterhuis WJ (2014) Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics. Clin Cancer Res 20:2831\u20132837. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-3141","journal-title":"Clin Cancer Res"},{"key":"4216_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0079-6123(08)61797-5","volume":"104","author":"T Herdegen","year":"1995","unstructured":"Herdegen T, Zimmermann M (1995) Immediate early genes (IEGs) encoding for inducible transcription factors (ITFs) and neuropeptides in the nervous system: Functional network for long-term plasticity and pain. Prog Brain Res 104:299\u2013321. https:\/\/doi.org\/10.1016\/S0079-6123(08)61797-5","journal-title":"Prog Brain Res"},{"key":"4216_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/(SICI)1099-1573(199908\/09)13:5<380::AID-PTR463>3.0.CO;2-M","volume":"13","author":"A Hirazumi","year":"1999","unstructured":"Hirazumi A, Furusawa E (1999) An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phyther Res 13:380\u2013387. https:\/\/doi.org\/10.1002\/(SICI)1099-1573(199908\/09)13:5%3c380::AID-PTR463%3e3.0.CO;2-M","journal-title":"Phyther Res"},{"key":"4216_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/J.FOODCHEM.2009.05.053","volume":"118","author":"K Kamiya","year":"2010","unstructured":"Kamiya K, Hamabe W, Tokuyama S et al (2010) Inhibitory effect of anthraquinones isolated from the Noni (Morinda citrifolia) root on animal A-, B- and Y-families of DNA polymerases and human cancer cell proliferation. Food Chem 118:725\u2013730. https:\/\/doi.org\/10.1016\/J.FOODCHEM.2009.05.053","journal-title":"Food Chem"},{"key":"4216_CR40","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","volume":"268","author":"L Kang","year":"2021","unstructured":"Kang L, Tian Y, Xu S, Chen H (2021) Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. J Neurol 268:3269\u20133282. https:\/\/doi.org\/10.1007\/s00415-020-09942-w","journal-title":"J Neurol"},{"key":"4216_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22031393","volume":"22","author":"T Kawashiri","year":"2021","unstructured":"Kawashiri T, Mine K, Kobayashi D et al (2021) Therapeutic agents for oxaliplatin-induced peripheral neuropathy; experimental and clinical evidence. Int J Mol Sci 22:1\u201325. https:\/\/doi.org\/10.3390\/ijms22031393","journal-title":"Int J Mol Sci"},{"key":"4216_CR42","doi-asserted-by":"publisher","unstructured":"Kawashiri T, Egashira N, Kurobe K et al (2012) L type Ca 2+channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats. Mol Pain 8. https:\/\/doi.org\/10.1186\/1744-8069-8-7","DOI":"10.1186\/1744-8069-8-7"},{"key":"4216_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.lfs.2015.03.013","volume":"130","author":"ST Kim","year":"2015","unstructured":"Kim ST, Chung YH, Lee HS et al (2015) Protective effects of phosphatidylcholine on oxaliplatin-induced neuropathy in rats. Life Sci 130:81\u201387. https:\/\/doi.org\/10.1016\/j.lfs.2015.03.013","journal-title":"Life Sci"},{"key":"4216_CR44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2826.2008.01734.x","volume":"20","author":"KJ Kov\u00e1cs","year":"2008","unstructured":"Kov\u00e1cs KJ (2008) Measurement of Immediate-Early Gene Activation- c-fos and Beyond. J Neuroendocrinol 20:665\u2013672. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01734.x","journal-title":"J Neuroendocrinol"},{"issue":"5259","key":"4216_CR45","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680\u2013685. https:\/\/doi.org\/10.1038\/227680a0","journal-title":"Nature"},{"key":"4216_CR46","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/J.PAIN.2013.06.043","volume":"154","author":"B Liu","year":"2013","unstructured":"Liu B, Fan L, Balakrishna S et al (2013) TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain 154:2169\u20132177. https:\/\/doi.org\/10.1016\/J.PAIN.2013.06.043","journal-title":"Pain"},{"key":"4216_CR47","doi-asserted-by":"publisher","first-page":"e0170814","DOI":"10.1371\/JOURNAL.PONE.0170814","volume":"12","author":"PGS Makker","year":"2017","unstructured":"Makker PGS, Duffy SS, Lees JG et al (2017) Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy. PLoS ONE 12:e0170814. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0170814","journal-title":"PLoS ONE"},{"key":"4216_CR48","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s43450-020-00087-5","volume":"30","author":"AD Marinho","year":"2020","unstructured":"Marinho AD, Silveira JAM, Chaves-Filho AJM et al (2020) Protective effects of a lipid transfer protein isolated from morinda citrifolia seeds in gentamicin-induced nephrotoxicity in rats. Rev Bras Farmacogn 30:568\u2013576. https:\/\/doi.org\/10.1007\/s43450-020-00087-5","journal-title":"Rev Bras Farmacogn"},{"key":"4216_CR49","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/J.PHAREP.2016.03.001","volume":"68","author":"S Mizoguchi","year":"2016","unstructured":"Mizoguchi S, Andoh T, Yakura T, Kuraishi Y (2016) Involvement of c-Myc-mediated transient receptor potential melastatin 8 expression in oxaliplatin-induced cold allodynia in mice. Pharmacol Reports 68:645\u2013648. https:\/\/doi.org\/10.1016\/J.PHAREP.2016.03.001","journal-title":"Pharmacol Reports"},{"key":"4216_CR50","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00520-014-2132-4","volume":"22","author":"M Nagashima","year":"2014","unstructured":"Nagashima M, Ooshiro M, Moriyama A et al (2014) Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients. Support Care Cancer 22:1579\u20131584. https:\/\/doi.org\/10.1007\/s00520-014-2132-4","journal-title":"Support Care Cancer"},{"key":"4216_CR51","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1248\/bpb.b17-00243","volume":"40","author":"T Nakagawa","year":"2017","unstructured":"Nakagawa T, Kaneko S (2017) Roles of transient receptor potential ankyrin 1 in oxaliplatin-induced peripheral neuropathy. Biol Pharm Bull 40:947\u2013953. https:\/\/doi.org\/10.1248\/bpb.b17-00243","journal-title":"Biol Pharm Bull"},{"key":"4216_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18549\/PharmPract.2022.2.2635","volume":"20","author":"S Palapinyo","year":"2022","unstructured":"Palapinyo S, Klaewsongkram J, Sriuranpong V, Areepium N (2022) Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: a 5-year retrospective study. Pharm Pract (Granada) 20:1\u20138. https:\/\/doi.org\/10.18549\/PharmPract.2022.2.2635","journal-title":"Pharm Pract (Granada)"},{"key":"4216_CR53","doi-asserted-by":"publisher","unstructured":"Pan JZ, Wang Z, Sun W et al (2024) ATF3 is a neuron\u2010specific biomarker for spinal cord injury and ischaemic stroke. Clin Transl Med 14. https:\/\/doi.org\/10.1002\/ctm2.1650","DOI":"10.1002\/ctm2.1650"},{"key":"4216_CR54","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.18632\/oncotarget.22471","volume":"9","author":"S Pathak","year":"2018","unstructured":"Pathak S, Sushmitha S, Banerjee A et al (2018) Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients. Oncotarget 9:7739\u20137748","journal-title":"Oncotarget"},{"key":"4216_CR55","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1211\/JPP.59.12.0001","volume":"59","author":"AD Pawlus","year":"2007","unstructured":"Pawlus AD, Kinghorn AD (2007) Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J Pharm Pharmacol 59:1587\u20131609. https:\/\/doi.org\/10.1211\/JPP.59.12.0001","journal-title":"J Pharm Pharmacol"},{"key":"4216_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A et al (2020) The arrive guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18:1\u201312. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLoS Biol"},{"key":"4216_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.taap.2018.01.001","volume":"340","author":"AF Pereira","year":"2018","unstructured":"Pereira AF, de Oliveira FFB, de Freitas Alves BW et al (2018) Neurotoxic effect of oxaliplatin: Comparison with its oxalate-free analogue cis-[PtII(1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)] (LLC-1402) in mice. Toxicol Appl Pharmacol 340:77\u201384. https:\/\/doi.org\/10.1016\/j.taap.2018.01.001","journal-title":"Toxicol Appl Pharmacol"},{"key":"4216_CR58","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s12640-021-00442-x","volume":"39","author":"AF Pereira","year":"2021","unstructured":"Pereira AF, Lisboa MRP, de Freitas Alves BW et al (2021) Endocannabinoid system attenuates oxaliplatin-induced peripheral sensory neuropathy through the activation of CB1 receptors. Neurotox Res 39:1782\u20131799. https:\/\/doi.org\/10.1007\/s12640-021-00442-x","journal-title":"Neurotox Res"},{"key":"4216_CR59","doi-asserted-by":"publisher","unstructured":"Pereira AF, Pereira LMS, Silva CMP et al (2019) Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice. Neurosci Lett 709. https:\/\/doi.org\/10.1016\/j.neulet.2019.134378","DOI":"10.1016\/j.neulet.2019.134378"},{"key":"4216_CR60","doi-asserted-by":"publisher","unstructured":"Pontes RB, Lisboa MRP, Pereira AF et al (2019) Involvement of endothelin receptors in peripheral sensory neuropathy induced by oxaliplatin in mice. Neurotox Res 36. https:\/\/doi.org\/10.1007\/s12640-019-00074-2","DOI":"10.1007\/s12640-019-00074-2"},{"key":"4216_CR61","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/ajco.12694","volume":"13","author":"JN Pulvers","year":"2017","unstructured":"Pulvers JN, Marx G (2017) Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review. Asia Pac J Clin Oncol 13:345\u2013355","journal-title":"Asia Pac J Clin Oncol"},{"key":"4216_CR63","doi-asserted-by":"publisher","unstructured":"Recalde MD, Miguel CA, Noya-Riob\u00f3 M V et al (2020) Resveratrol exerts anti-oxidant and anti-inflammatory actions and prevents oxaliplatin-induced mechanical and thermal allodynia. Brain Res 1748. https:\/\/doi.org\/10.1016\/J.BRAINRES.2020.147079","DOI":"10.1016\/J.BRAINRES.2020.147079"},{"key":"4216_CR64","doi-asserted-by":"publisher","unstructured":"Rimola V, Osthues T, K\u00f6nigs V et al (2021) Oxaliplatin causes transient changes in trpm8 channel activity. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22094962","DOI":"10.3390\/ijms22094962"},{"key":"4216_CR65","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1200\/JCO.2015.60.9107\/SUPPL_FILE\/PROTOCOL_2015.609107.PDF","volume":"33","author":"HJ Schmoll","year":"2015","unstructured":"Schmoll HJ, Tabernero J, Maroun J et al (2015) Capecitabine plus oxaliplatin compared with fluorouracil\/folinic acid as adjuvant therapy for stage III colon cancer: Final Results of the NO16968 randomized controlled phase III trial. J Clin Oncol 33:3733\u20133740. https:\/\/doi.org\/10.1200\/JCO.2015.60.9107\/SUPPL_FILE\/PROTOCOL_2015.609107.PDF","journal-title":"J Clin Oncol"},{"key":"4216_CR66","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","volume":"25","author":"J Sedlak","year":"1968","unstructured":"Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent. Anal Biochem 25:192\u2013205. https:\/\/doi.org\/10.1016\/0003-2697(68)90092-4","journal-title":"Anal Biochem"},{"key":"4216_CR67","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nrneurol.2014.211","volume":"10","author":"M Sisignano","year":"2014","unstructured":"Sisignano M, Baron R, Scholich K, Geisslinger G (2014) Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol 10:694\u2013707. https:\/\/doi.org\/10.1038\/nrneurol.2014.211","journal-title":"Nat Rev Neurol"},{"key":"4216_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biochi.2018.03.011","volume":"149","author":"AA Souza","year":"2018","unstructured":"Souza AA, Costa AS, Campos DCO et al (2018) Lipid transfer protein isolated from noni seeds displays antibacterial activity in vitro and improves survival in lethal sepsis induced by CLP in mice. Biochimie 149:9\u201317. https:\/\/doi.org\/10.1016\/j.biochi.2018.03.011","journal-title":"Biochimie"},{"key":"4216_CR69","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1111\/jns.12335","volume":"24","author":"NP Staff","year":"2019","unstructured":"Staff NP, Cavaletti G, Islam B et al (2019) Platinum-induced peripheral neurotoxicity: from pathogenesis to treatment. J Peripher Nerv Syst 24:S26\u2013S39","journal-title":"J Peripher Nerv Syst"},{"key":"4216_CR70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","volume":"10","author":"H Starobova","year":"2017","unstructured":"Starobova H, Vetter I (2017) Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci 10:174. https:\/\/doi.org\/10.3389\/fnmol.2017.00174","journal-title":"Front Mol Neurosci"},{"key":"4216_CR71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/14656566.2012.643870","volume":"13","author":"A Stein","year":"2012","unstructured":"Stein A, Arnold D (2012) Oxaliplatin: a review of approved uses. Expert Opin Pharmacother 13:125\u2013137","journal-title":"Expert Opin Pharmacother"},{"key":"4216_CR72","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1021\/np0495985","volume":"68","author":"BN Su","year":"2005","unstructured":"Su BN, Pawlus AD, Jung HA et al (2005) Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. J Nat Prod 68:592\u2013595. https:\/\/doi.org\/10.1021\/np0495985","journal-title":"J Nat Prod"},{"key":"4216_CR73","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2009.356","volume":"29","author":"A Tesniere","year":"2010","unstructured":"Tesniere A, Schlemmer F, Boige V et al (2010) Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 29:482\u2013491. https:\/\/doi.org\/10.1038\/onc.2009.356","journal-title":"Oncogene"},{"key":"4216_CR74","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/01.anes.0000435634.34709.65","volume":"120","author":"S Toyama","year":"2014","unstructured":"Toyama S, Shimoyama N, Ishida Y et al (2014) Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies. Anesthesiology 120:459\u2013473. https:\/\/doi.org\/10.1097\/01.anes.0000435634.34709.65","journal-title":"Anesthesiology"},{"key":"4216_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/BS.IRN.2019.05.001","volume":"145","author":"A Trecarichi","year":"2019","unstructured":"Trecarichi A, Flatters SJL (2019) Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy. Int Rev Neurobiol 145:83\u2013126. https:\/\/doi.org\/10.1016\/BS.IRN.2019.05.001","journal-title":"Int Rev Neurobiol"},{"key":"4216_CR76","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1006\/mcne.1999.0814","volume":"15","author":"H Tsujino","year":"2000","unstructured":"Tsujino H, Kondo E, Fukuoka T et al (2000) Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci 15:170\u2013182. https:\/\/doi.org\/10.1006\/mcne.1999.0814","journal-title":"Mol Cell Neurosci"},{"key":"4216_CR77","doi-asserted-by":"publisher","first-page":"113936","DOI":"10.1016\/j.bcp.2020.113936","volume":"177","author":"M Ulrich","year":"2020","unstructured":"Ulrich M, Wissenbach U, Thiel G (2020) The super-cooling compound icilin stimulates c-Fos and Egr-1 expression and activity involving TRPM8 channel activation, Ca2+ ion influx and activation of the ternary complex factor Elk-1. Biochem Pharmacol 177:113936. https:\/\/doi.org\/10.1016\/j.bcp.2020.113936","journal-title":"Biochem Pharmacol"},{"key":"4216_CR78","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1007\/s10753-017-0645-y","volume":"40","author":"YS Wang","year":"2017","unstructured":"Wang YS, Li YY, Cui W et al (2017) Melatonin attenuates pain hypersensitivity and decreases astrocyte-mediated spinal neuroinflammation in a rat model of oxaliplatin-induced pain. Inflammation 40:2052\u20132061. https:\/\/doi.org\/10.1007\/s10753-017-0645-y","journal-title":"Inflammation"},{"key":"4216_CR79","doi-asserted-by":"publisher","unstructured":"Wang J, Zhang H, Yin X, Bian Y (2022) Oxaliplatin induces immunogenic cell death in human and murine laryngeal cancer. J Oncol 2022. https:\/\/doi.org\/10.1155\/2022\/3760766","DOI":"10.1155\/2022\/3760766"},{"key":"4216_CR80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/JNS.12432","volume":"26","author":"G Wei","year":"2021","unstructured":"Wei G, Gu Z, Gu J et al (2021) Platinum accumulation in oxaliplatin-induced peripheral neuropathy. J Peripher Nerv Syst 26:35\u201342. https:\/\/doi.org\/10.1111\/JNS.12432","journal-title":"J Peripher Nerv Syst"},{"key":"4216_CR81","doi-asserted-by":"publisher","unstructured":"Xu L, Han Y, Chen X et al (2020) Molecular mechanisms underlying menthol binding and activation of TRPM8 ion channel. Nat Commun 11. https:\/\/doi.org\/10.1038\/s41467-020-17582-x","DOI":"10.1038\/s41467-020-17582-x"},{"key":"4216_CR82","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jphs.2018.10.006","volume":"138","author":"S Yamamoto","year":"2018","unstructured":"Yamamoto S, Egashira N, Tsuda M, Masuda S (2018) Riluzole prevents oxaliplatin-induced cold allodynia via inhibition of overexpression of transient receptor potential melastatin 8 in rats. J Pharmacol Sci 138:214\u2013217. https:\/\/doi.org\/10.1016\/j.jphs.2018.10.006","journal-title":"J Pharmacol Sci"},{"key":"4216_CR84","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/ijms20061451","volume":"20","author":"R Zajaczkowsk\u0105","year":"2019","unstructured":"Zajaczkowsk\u0105 R, Kocot-K\u0119pska M, Leppert W et al (2019) Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci 20:1451","journal-title":"Int J Mol Sci"},{"key":"4216_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1744-8069-8-55","volume":"8","author":"M Zhao","year":"2012","unstructured":"Zhao M, Isami K, Nakamura S et al (2012) Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain 8:55. https:\/\/doi.org\/10.1186\/1744-8069-8-55","journal-title":"Mol Pain"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04216-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04216-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04216-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:12:30Z","timestamp":1759983150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04216-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4216"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04216-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies with animals were in accordance with the ethical standards of the institution where the studies were conducted. The study was approved by the Ethics Committee on the Use of Animals of the Federal University of Cear\u00e1 (number: 36\/17).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}